1. Home
  2. FBIO vs GDO Comparison

FBIO vs GDO Comparison

Compare FBIO & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • GDO
  • Stock Information
  • Founded
  • FBIO 2006
  • GDO 2009
  • Country
  • FBIO United States
  • GDO United States
  • Employees
  • FBIO N/A
  • GDO N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • GDO Finance Companies
  • Sector
  • FBIO Health Care
  • GDO Finance
  • Exchange
  • FBIO Nasdaq
  • GDO Nasdaq
  • Market Cap
  • FBIO 88.7M
  • GDO 89.6M
  • IPO Year
  • FBIO N/A
  • GDO N/A
  • Fundamental
  • Price
  • FBIO $2.75
  • GDO $11.54
  • Analyst Decision
  • FBIO Strong Buy
  • GDO
  • Analyst Count
  • FBIO 2
  • GDO 0
  • Target Price
  • FBIO $16.50
  • GDO N/A
  • AVG Volume (30 Days)
  • FBIO 341.4K
  • GDO 39.4K
  • Earning Date
  • FBIO 11-14-2025
  • GDO 01-01-0001
  • Dividend Yield
  • FBIO N/A
  • GDO 9.81%
  • EPS Growth
  • FBIO N/A
  • GDO N/A
  • EPS
  • FBIO N/A
  • GDO N/A
  • Revenue
  • FBIO $62,303,000.00
  • GDO N/A
  • Revenue This Year
  • FBIO $31.85
  • GDO N/A
  • Revenue Next Year
  • FBIO $44.43
  • GDO N/A
  • P/E Ratio
  • FBIO N/A
  • GDO N/A
  • Revenue Growth
  • FBIO N/A
  • GDO N/A
  • 52 Week Low
  • FBIO $1.33
  • GDO $11.21
  • 52 Week High
  • FBIO $4.20
  • GDO $13.04
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 55.02
  • GDO 52.53
  • Support Level
  • FBIO $2.40
  • GDO $11.36
  • Resistance Level
  • FBIO $2.76
  • GDO $11.72
  • Average True Range (ATR)
  • FBIO 0.16
  • GDO 0.16
  • MACD
  • FBIO 0.03
  • GDO 0.02
  • Stochastic Oscillator
  • FBIO 94.59
  • GDO 88.88

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: